Kura Oncology
KURA • NASDAQ
Kura Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Troy Edward Wilson, with a market cap of $683.7M.
CEOTroy Edward Wilson
Next Earnings
Upcoming earnings announcement for Kura Oncology
Date
Thursday, April 30, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.80
Revenue Estimate
$21.7M
Earnings History
Past 12 earnings reports for Kura Oncology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.92Est: -$0.58 | -58.6% | $17.3MEst: $33.2M | -47.8% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.85Est: -$0.63 | -34.9% | $20.8MEst: $62.0M | -66.5% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.75Est: -$0.16 | -368.7% | $15.3MEst: $95.7M | -84.0% | 10-Q |
| May 1, 2025 | Q1 2025 | -$0.66Est: -$0.60 | -10.0% | $14.1MEst: $39.1M | -63.9% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.22Est: -$0.64 | +65.6% | $53.9MEst: $8.5M | +533.9% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.63Est: -$0.63 | 0.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.59Est: -$0.63 | +6.3% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.59Est: -$0.55 | -7.3% | - | — | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$0.55Est: -$0.55 | 0.0% | -Est: - | — | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.50Est: -$0.55 | +9.1% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.53Est: -$0.57 | +7.0% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.50Est: -$0.54 | +7.4% | - | — | — |